Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Fasted vs Fed State: Bioavailability Drops 40% With Food

Melanotan-1 is a small peptide (13 amino acids) absorbed through passive diffusion at the subcutaneous injection site, but gastrointestinal peptidase activity and splanchnic blood flow diversion during digestion significantly impact systemic availability even

This comparison does not assign a generated winner or score.

  • Melanotan-1 is a small peptide (13 amino acids) absorbed through passive diffusion at the subcutaneous injection site, but gastrointestinal peptidase activity and splanchnic blood flow diversion during digestion significantly impact systemic availability even for subcutaneous administration. Injecting within two hours of a meal reduces effective plasma concentration by 30–40%. Not because the peptide degrades, but because increased splanchnic circulation and elevated insulin during postprandial periods alter subcutaneous blood flow patterns and peptide clearance rates.
  • Insulin, elevated during and after meals, increases vascular permeability and accelerates peptide transport from subcutaneous tissue into systemic circulation. But it also accelerates renal clearance and hepatic first-pass metabolism of small peptides. The net effect is faster absorption but shorter duration of therapeutic plasma levels. A fasted injection at 8:00 AM produces a gradual absorption curve with sustained plasma levels for 90–120 minutes; the same dose injected at 12:30 PM after lunch produces a sharp peak at 60 minutes but drops below threshold by 90 minutes.
  • We recommend administering melanotan-1 at least two hours after the last meal and at least one hour before the next. Morning fasted protocols (injection upon waking, UV exposure mid-morning) consistently outperform fed-state afternoon protocols in side-by-side tanning response comparisons. Users also report significantly lower nausea incidence with fasted morning dosing. Likely because ghrelin is elevated in fasted states, which partially counteracts alpha-MSH's appetite-suppressing effects.
More references

Related material